These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 2540776)

  • 1. The biology of cachectin/TNF--a primary mediator of the host response.
    Beutler B; Cerami A
    Annu Rev Immunol; 1989; 7():625-55. PubMed ID: 2540776
    [No Abstract]   [Full Text] [Related]  

  • 2. The complex regulation and biology of TNF (cachectin).
    Beutler B
    Crit Rev Oncog; 1990; 2(1):9-18. PubMed ID: 2091751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor: a plurifunctional mediator of acute inflammation.
    Warren JS; Ward PA; Johnson KJ
    Mod Pathol; 1988 May; 1(3):242-7. PubMed ID: 2853361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
    J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta).
    Ruddle NH
    Curr Opin Immunol; 1992 Jun; 4(3):327-32. PubMed ID: 1329840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning and characteristics of the human genome locus containing genes of a second type of receptor (75 kDa) for tumor necrosis factor and lymphotoxin].
    Turetskaia RL; Udalova IA; Kuprash DV; Terskikh AV; Nedospasov SA
    Dokl Akad Nauk SSSR; 1991; 320(5):1258-61. PubMed ID: 1666995
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin.
    Jäättelä M
    Lab Invest; 1991 Jun; 64(6):724-42. PubMed ID: 1646350
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.
    Galloway CJ; Madanat MS; Sarr T; Espevik T; Dumas ML; Mitra G; Ranges GE
    Eur J Immunol; 1992 Nov; 22(11):3045-8. PubMed ID: 1330580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and structural properties of two distinct TNF receptors on human cells.
    Loetscher H
    Immunol Ser; 1992; 56():161-87. PubMed ID: 1312871
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 14. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Beutler B; Cerami A
    Nature; 1986 Apr 17-23; 320(6063):584-8. PubMed ID: 3010124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.